Cargando…
Galectin-3 Inhibitors Suppress Anoikis Resistance and Invasive Capacity in Thyroid Cancer Cells
Accumulating evidence suggests that galectin-3 is a histologic marker of thyroid cancer. However, the pharmacological lectin-based approach has not been well studied. In the present study, we aimed to investigate the therapeutic potential of novel galectin-3 inhibitors by treating thyroid cancer cel...
Autores principales: | Lee, Jie-Jen, Hsu, Yi-Chiung, Li, Ying-Syuan, Cheng, Shih-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124007/ https://www.ncbi.nlm.nih.gov/pubmed/34035807 http://dx.doi.org/10.1155/2021/5583491 |
Ejemplares similares
-
Heme Oxygenase-1 Inhibitors Induce Cell Cycle Arrest and Suppress Tumor Growth in Thyroid Cancer Cells
por: Yang, Po-Sheng, et al.
Publicado: (2018) -
Inhibition of p600 Expression Suppresses Both Invasiveness and Anoikis Resistance of Gastric Cancer
por: Sakai, Hiroshi, et al.
Publicado: (2011) -
PRPH2 Activates Hippo Signalling and Suppresses the Invasion and Anoikis Inhibition of Laryngeal Cancer
por: Dong, KaiFeng, et al.
Publicado: (2019) -
Integrin β4 promotes invasion and anoikis resistance of papillary thyroid carcinoma and is consistently overexpressed in lymphovascular tumor thrombus
por: Li, Jian, et al.
Publicado: (2019) -
LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling
por: Cheng, Yang, et al.
Publicado: (2018)